Authors: DECKER CJ LAITINEN LM BRIDSON GW RAYBUCK SA TUNG RD CHATURVEDI PR

Citation: Cj. Decker et al., METABOLISM OF AMPRENAVIR IN LIVER-MICROSOMES - ROLE OF CYP3A4 INHIBITION FOR DRUG-INTERACTIONS, Journal of pharmaceutical sciences, 87(7), 1998, pp. 803-807

Authors: NAVIA MA TUNG RD CHATURVEDI PR RAO BG PARTALEDIS JA KIM EE

Citation: Ma. Navia et al., STRUCTURE-BASED DRUG DESIGN OF HIV PROTEASE INHIBITORS, The FASEB journal, 10(6), 1996, pp. 2436-2436

Authors: LIVINGSTON DJ PAZHANISAMY S PARTALEDIS JA TUNG RD

Citation: Dj. Livingston et al., RELEVANCE OF PLASMA-PROTEIN BINDING TO ANTIVIRAL ACTIVITY AND CLINICAL EFFICACY OF INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE - REPLY, The Journal of infectious diseases, 173(6), 1996, pp. 1525-1526

Authors: ARMISTEAD DM BADIA MC DEININGER DD DUFFY JP SAUNDERS JO TUNG RD THOMSON JA DECENZO MT FUTER O LIVINGSTON DJ MURCKO MA YAMASHITA MM NAVIA MA

Citation: Dm. Armistead et al., DESIGN, SYNTHESIS AND STRUCTURE OF NON-MACROCYCLIC INHIBITORS OF FKBP12, THE MAJOR BINDING-PROTEIN FOR THE IMMUNOSUPPRESSANT FK506, Acta crystallographica. Section D, Biological crystallography, 51, 1995, pp. 522-528

Authors: LIVINGSTON DJ PAZHANISAMY S PORTER DJT PARTALEDIS JA TUNG RD PAINTER GR

Citation: Dj. Livingston et al., WEAK BINDING OF VX-478 TO HUMAN PLASMA-PROTEINS AND IMPLICATIONS FOR ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS THERAPY, The Journal of infectious diseases, 172(5), 1995, pp. 1238-1245

Authors: KIM EE BAKER CT DWYER MD MURCKO MA RAO BG TUNG RD NAVIA MA

Citation: Ee. Kim et al., CRYSTAL-STRUCTURE OF HIV-1 PROTEASE IN COMPLEX WITH VX-478, A POTENT AND ORALLY BIOAVAILABLE INHIBITOR OF THE ENZYME, Journal of the American Chemical Society, 117(3), 1995, pp. 1181-1182